T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
DT Midstream
DTM
$13.9B
| $2.86M | ﹤0.01% |
46,864
+2,997
| +7% | +$167K |
|
1402
Glaukos
GKOS
$11.2B
| $2.86M | ﹤0.01% |
30,364
-283,560
| -90% | -$25.3M |
|
1403
Envista
NVST
$4.61B
| $2.86M | ﹤0.01% |
133,887
+8,380
| +7% | +$190K |
|
1404
Teva Pharmaceuticals
TEVA
$42.6B
| $2.85M | ﹤0.01% |
201,849
+36,295
| +22% | +$458K |
|
1405
Sunrun
RUN
$2.37B
| $2.85M | ﹤0.01% |
215,836
+2,056
| +1% | +$28.3K |
|
1406
Bank OZK
OZK
$5.69B
| $2.84M | ﹤0.01% |
62,444
+3,301
| +6% | +$148K |
|
1407
Macy's
M
$6.26B
| $2.83M | ﹤0.01% |
141,529
+8,403
| +6% | +$162K |
|
1408
Coca-Cola Europacific Partners
CCEP
$47.3B
| $2.83M | ﹤0.01% |
40,442
+4,741
| +13% | +$326K |
|
1409
Kyndryl
KD
$2.85B
| $2.82M | ﹤0.01% |
129,703
+6,959
| +6% | +$148K |
|
1410
Central Garden & Pet Co Class A
CENTA
$2.43B
| $2.82M | ﹤0.01% |
76,262
+3,493
| +5% | +$124K |
|
1411
Zurn Elkay Water Solutions
ZWS
$8.46B
| $2.81M | ﹤0.01% |
84,095
+5,536
| +7% | +$170K |
|
1412
PagerDuty
PD
$876M
| $2.81M | ﹤0.01% |
123,910
-14,808
| -11% | -$352K |
|
1413
Boston Beer
SAM
$1.89B
| $2.81M | ﹤0.01% |
9,214
+24
| +0.3% | +$8.01K |
|
1414
Itron
ITRI
$4.49B
| $2.8M | ﹤0.01% |
30,298
+1,765
| +6% | +$142K |
|
1415
Insteel Industries
IIIN
$635M
| $2.79M | ﹤0.01% |
73,061
-3,863
| -5% | -$138K |
|
1416
NerdWallet
NRDS
$617M
| $2.79M | ﹤0.01% |
189,686
-11,261
| -6% | -$174K |
|
1417
FIVE9
FIVN
$2.33B
| $2.79M | ﹤0.01% |
44,827
+2,480
| +6% | +$172K |
|
1418
Group 1 Automotive
GPI
$3.17B
| $2.77M | ﹤0.01% |
9,460
+515
| +6% | +$141K |
|
1419
First Financial Bankshares
FFIN
$5.01B
| $2.76M | ﹤0.01% |
84,096
+4,736
| +6% | +$145K |
|
1420
Amylyx Pharmaceuticals
AMLX
$2.6B
| $2.76M | ﹤0.01% |
970,555
+75,775
| +8% | +$991K |
|
1421
FirstCash
FCFS
$9.28B
| $2.75M | ﹤0.01% |
21,561
+1,367
| +7% | +$158K |
|
|
PCH
1422
DELISTED
PotlatchDeltic
PCH
| $2.75M | ﹤0.01% |
58,479
-46,662
| -44% | -$2.15M |
|
1423
Assured Guaranty
AGO
$3.29B
| $2.73M | ﹤0.01% |
31,310
+302
| +1% | +$25.4K |
|
1424
Allegiant Air
ALGT
$2.36B
| $2.73M | ﹤0.01% |
36,304
-915
| -2% | -$69.4K |
|
1425
Organon & Co
OGN
$3.59B
| $2.73M | ﹤0.01% |
145,205
+9,491
| +7% | +$163K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.